Insights

Expanding Global Presence BioIVT's recent acquisition of Cytesbiotech and its active participation in industry events demonstrate a strategic focus on expanding its portfolio and market reach, presenting opportunities to introduce complementary products and services to its growing customer base.

Innovation and Partnerships The company's collaborations with Seqster and IDBS highlight its openness to integrating advanced technology solutions, offering sales prospects for innovative data management, sample processing, and analytics tools tailored to biospecimen research.

Increasing Research Activities Frequent engagement in leading medical and biotech conferences signals active research and development initiatives, creating opportunities to offer new biological specimens, research services, and customized solutions aligned with emerging trends.

Focus on Precision Medicine BioIVT's emphasis on providing control and disease state samples, coupled with high-quality cellular and tissue solutions, aligns well with the growing demand for personalized therapies and diagnostic development, offering targeted sales opportunities in precision medicine markets.

BioIVT Tech Stack

BioIVT uses 8 technology products and services including Salesforce CPQ, Cybot, Apple iCloud Mail, and more. Explore BioIVT's tech stack below.

  • Salesforce CPQ
    Configure Price Quote
  • Cybot
    Cookie Compliance
  • Apple iCloud Mail
    Email
  • Linkedin Sign-in
    Identity Verification
  • RequireJS
    Javascript Frameworks
  • Lightbox
    Javascript Libraries
  • Microsoft Project
    Project Management
  • Microsoft Exchange
    Storage

Media & News

BioIVT's Email Address Formats

BioIVT uses at least 1 format(s):
BioIVT Email FormatsExamplePercentage
FLast@bioivt.comJDoe@bioivt.com
99%
First_Last@bioivt.comJohn_Doe@bioivt.com
1%

Frequently Asked Questions

Where is BioIVT's headquarters located?

Minus sign iconPlus sign icon
BioIVT's main headquarters is located at 175 Crossways Park Drive West Suite 200 Woodbury, New York 11797 United States. The company has employees across 2 continents, including North AmericaEurope.

What is BioIVT's phone number?

Minus sign iconPlus sign icon
You can contact BioIVT's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BioIVT's official website and social media links?

Minus sign iconPlus sign icon
BioIVT's official website is bioivt.com and has social profiles on LinkedInCrunchbase.

What is BioIVT's SIC code NAICS code?

Minus sign iconPlus sign icon
BioIVT's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioIVT have currently?

Minus sign iconPlus sign icon
As of May 2026, BioIVT has approximately 479 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: R. H.Chief Information Officer: B. P.Chief Human Resources Officer: K. O.. Explore BioIVT's employee directory with LeadIQ.

What industry does BioIVT belong to?

Minus sign iconPlus sign icon
BioIVT operates in the Biotechnology Research industry.

What technology does BioIVT use?

Minus sign iconPlus sign icon
BioIVT's tech stack includes Salesforce CPQCybotApple iCloud MailLinkedin Sign-inRequireJSLightboxMicrosoft ProjectMicrosoft Exchange.

What is BioIVT's email format?

Minus sign iconPlus sign icon
BioIVT's email format typically follows the pattern of FLast@bioivt.com. Find more BioIVT email formats with LeadIQ.

How much funding has BioIVT raised to date?

Minus sign iconPlus sign icon
As of May 2026, BioIVT has raised $45M in funding. The last funding round occurred on Jul 16, 2013 for $45M.

When was BioIVT founded?

Minus sign iconPlus sign icon
BioIVT was founded in 1981.

BioIVT

Biotechnology ResearchNew York, United States201-500 Employees

BioIVT, formerly BioreclamationIVT, is a leading global provider of high-quality biological specimens and value-added services. We specialize in control and disease state samples including human and animal tissues, cell products, blood and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples.

Our Research Services team works collaboratively with clients to provide in vitro hepatic modeling solutions. And as the world’s premier supplier of ADME-Tox model systems, including hepatocytes and subcellular fractions, BioIVT enables scientists to better understand the pharmacokinetics and drug metabolism of newly discovered compounds and the effects on disease processes. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®.

Section iconCompany Overview

Headquarters
175 Crossways Park Drive West Suite 200 Woodbury, New York 11797 United States
Phone number
Website
bioivt.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1981
Employees
201-500

Section iconFunding & Financials

  • $45M

    BioIVT has raised a total of $45M of funding over 3 rounds. Their latest funding round was raised on Jul 16, 2013 in the amount of $45M.

  • $100M$250M

    BioIVT's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $45M

    BioIVT has raised a total of $45M of funding over 3 rounds. Their latest funding round was raised on Jul 16, 2013 in the amount of $45M.

  • $100M$250M

    BioIVT's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.